Elsevier

Virology

Volume 204, Issue 1, October 1994, Pages 123-131
Virology

Regular Article
HIV-1 Rev Is Capable of Shuttling between the Nucleus and Cytoplasm

https://doi.org/10.1006/viro.1994.1516Get rights and content

Abstract

The mechanism by which Rev facilitates the export, and consequently, the translation of the structural protein mRNAs of the human immunodeficiency virus type 1 remains undefined. Previous immunolocalization has determined that Rev is predominately in the nucleus with significant accumulation in the nucleolus, a localization consistent with the assumed site of Rev action. To determine whether the subcellular distribution is more dynamic than what was indicated by the original studies, the capacity of Rev to shuttle between the nucleus and cytoplasm was examined. It was observed that treatment of cells with DRB or actinomycin D resulted in a dramatic alteration in Rev distribution, the majority of the protein being found in the cytoplasm. Removal of the drug resulted in a rapid accumulation of Rev in the nucleus indicating that the block to nuclear import was reversible. Subsequent studies indicated that the movement of Rev into the cytoplasm was a passive process while its accumulation in the nucleus was an active one, given that only the latter displayed sensitivity to temperature. Finally, it was demonstrated that, while extensive redistribution of Rev could be attained by inhibition of RNA polymerase I alone, Rev was still capable of inducing expression of HIV structural gene expression under these conditions. Consequently, Rev activity does not appear to be dependent on either an intact nucleolus or the accumulation of the protein in the nucleus.

References (0)

Cited by (85)

  • Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells

    2011, Biochimica et Biophysica Acta - Biomembranes
    Citation Excerpt :

    This series of processes are carried out by the direct interaction between the Rev protein and its structural RNA target, on such HIV-1 mRNAs, the specific region entitled the Rev responsive element (RRE) [35–37]. Furthermore, many studies regarding HIV-1 have suggested that Rev is shuttling between the cytoplasm and the nucleus of the host cells [12–15], mediated by the NLS (nuclear localization signal), the NOS (nucleolar targeting signal) [38] and the NES (nuclear export signal) of Rev itself [39–41]. As mentioned above, NIS region is also crucial for the cycle survival of HIV-1.

  • Posttranscriptional Control of HIV-1 and Other Retroviruses and Its Practical Applications

    2007, Advances in Pharmacology
    Citation Excerpt :

    Rev is a small 116‐aa nuclear/nucleolar protein (Cochrane et al., 1990b; Cullen et al., 1988; Felber et al., 1989b; Perkins et al., 1989; Venkatesh et al., 1990), and its nucleolar localization is critical for Rev function (Michienzi et al., 2006; Stauber et al., 1995, 1998). Rev was found to shuttle rapidly between the nucleus and cytoplasm (D'Agostino et al., 1995; Kalland et al., 1994; Love et al., 1998; Meyer and Malim, 1994; Neumann et al., 2001; Richard et al., 1994; Stauber et al., 1995; Szilvay et al., 1995; Wolff et al., 2006). Rev contains four functional determinants: nuclear localization signal (NLS), RNA‐binding domain (RBD), oligomerization domain flanking the NLS/RBD, and nuclear export signal (NES) (for reviews see Cochrane, 2004; Hope, 1999; Pavlakis and Felber, 1990; Pollard and Malim, 1998).

  • Human T-cell leukemia virus type I p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60 S ribosomal subunit

    2006, Journal of Biological Chemistry
    Citation Excerpt :

    However, both proteins appeared to localize more in the nucleoplasm at the higher concentration of AMD (Fig. 9A), suggesting that their nucleolar retention is partly dependent on RNA polymerase II and III transcription. In the same experiment, human immunodeficiency virus Rev-GFP was used as a positive control and was efficiently relocated to the cytoplasm following AMD treatment at either concentration, as reported previously (18, 19). We next used live cell imaging to investigate GFP-p30 recovery kinetics in response to AMD treatment.

View all citing articles on Scopus
View full text